https://pharmoniq.com/news/telix-pharmaceuticals-tlx400-tx-fap-therapy-long-term-outcomes PharmoniQ en 2026-08-27T14:10:49.048Z Telix Publishes Long-Term TLX400-Tx FAP Therapy Data FAP-targeted therapy, Telix Pharmaceuticals, radioligand therapy, precision oncology, clinical outcomes https://pharmoniq.com/news/eu-supplement-non-compliance-alerts-record-2026 PharmoniQ en 2026-08-27T08:47:02.758Z EU Non-Compliance Alerts for Supplements Hit Record High EU regulations, supplement compliance, food safety, regulatory enforcement, cross-border trade https://pharmoniq.com/news/fda-recalls-levothyroxine-thyroid-tablets-potency-problems PharmoniQ en 2026-08-26T14:10:49.869Z FDA Recalls Levothyroxine Tablets Over Potency Concerns levothyroxine, thyroid medication, FDA recall, drug potency, hormone replacement therapy